Henry Ν. C. Wong

Federal Grant PI High Impact

X.Q. Deng Presidential Chair Professor

UAMS

Also affiliated: Lyon 1 Université (2025); Toyobo (Japan) (1987); Library and Archives Canada (2005); Centre National de la Recherche Scientifique (2004–2025); Hong Kong Baptist University (2005–2010); Hong Kong Polytechnic University (1984); Bristol-Myers Squibb (Germany) (1983–2016); Jinan University (2015); Chinese University of Hong Kong (1973–2025); American University (1998); University of Basel (1975–1991); University of Toronto (1993–2011); Chinese Academy of Sciences (2001–2025); Hong Kong University of Science and Technology (1999); Shatin Hospital (2014–2019); Hospital for Sick Children (2011–2013); Toronto General Hospital (1993); University Grants Committee (2007–2012); Southern University of Science and Technology (2022–2023); ProQuest (United States) (2005); Victoria University of Wellington (1972); SAIC-GM (China) (2014); Bristol-Myers Squibb (United States) (1983–2016); Institute of Molecular Functional Materials (2011–2017); École Supérieure des Télécommunications (2005); City University of Hong Kong, Shenzhen Research Institute (2014); Bristol-Myers Squibb (Canada) (1985); Shanghai Advanced Research Institute (2003–2016); Shanghai Institute of Organic Chemistry (1984–2025); Chinese University of Hong Kong, Shenzhen (2013–2025); State Key Laboratory of Synthetic Chemistry (2002–2023); École Nationale Supérieure d'Architecture de Bretagne (2005); National Research Council Canada (1975); Chemical Synthesis Lab (2014–2025); École Nationale des Travaux Publics de l'État (2004–2025); Henan Key Laboratory of Organic Functional Molecules and Drug Innovation (2019); European Space Research and Technology Centre (2004); University College London (1975–1981); Carleton University (2005); Henan Normal University (2019); Zhejiang University (1999); University of Hong Kong (2004–2020)

48 h-index 624 pubs 9,326 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Henry N. C. Wong, the X.Q. Deng Presidential Chair Professor at the University of Arkansas for Medical Sciences, leads a research group that investigates the mechanisms and potential therapies for various diseases. His work has focused on conditions such as cutaneous T-cell lymphoma, including mycosis fungoides and Sézary syndrome, where he has contributed to understanding prognostic markers and developing prognostic models. His research also extends to the effects of specific therapeutic agents, such as Ibrutinib in ameliorating murine chronic graft-versus-host disease, and Polyphyllin D as an apoptosis inducer in drug-resistant cancer cells.

Professor Wong's research has been supported by federal grants, including an NIH award for his work on the epigenetic regulation of differentially expressed genes in cutaneous T-cell lymphoma. He is recognized as a high-impact researcher, evidenced by his h-index of 48 and over 9,300 citations across more than 600 publications. His collaborations within the University of Arkansas for Medical Sciences include notable work with Sophia Ly and Delice Kayishunge, each with whom he has co-authored six publications.

Metrics

h-index: 48
Publications: 624
Citations: 9,326

Positions

X.Q. Deng Presidential Chair Professor 2021–present

Chinese University of Hong Kong, Shenzhen School of Science and Engineering ORCID
X.Q. Deng Presidential Chair Professor publications 2022–2025

University of Arkansas for Medical Sciences ORCID

Selected Publications

Association Between Dietary Folate and Prostate Cancer Aggressiveness Among African Americans and European Americans (2026)

DOI OpenAlex
Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome (2025)

DOI OpenAlex
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma (2024)

Journal of Clinical Oncology 24 citations DOI OpenAlex
Cutaneous T-Cell Lymphoma (CTCL) Arising Post Kidney Transplant: A Review of Clinical Variants in the Literature (2023)

1 citation DOI OpenAlex
HyBryte™ use in early-stage cutaneous T-cell lymphoma (2023)

DOI OpenAlex
The effect of comorbid autoimmune gastrointestinal diseases on time to resolution of pyoderma gangrenosum: A retrospective review (2023)

1 citation DOI OpenAlex
266 Analysis of novel sezary syndrome genes in mycosis fungoides reveals genes common across stages and those associated with advanced stages (2023)

DOI OpenAlex
Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin (2023)

American Journal of Clinical Dermatology 22 citations DOI OpenAlex
A case of typical mycosis fungoides in an HIV-positive patient (2022)

DOI OpenAlex
34350 Treatment with rituximab for refractory adult dermatomyositis complicated with calcinosis cutis (2022)

1 citation DOI OpenAlex
Epidemiologic Trends of Cutaneous T-Cell Lymphoma in Arkansas Reveals Demographic Disparities (2022)

7 citations DOI OpenAlex
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides) (2022)

JAMA Dermatology 55 citations DOI OpenAlex
112 Gene expression changes in sezary syndrome patients following mogamulizumab treatment refines biomarker and immune profile (2022)

DOI OpenAlex